Rossari Biotech (BOM:543213) Long-Term Capital Lease Obligation : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Rossari Biotech Long-Term Capital Lease Obligation?

Rossari Biotech's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil.

Rossari Biotech's quarterly Long-Term Capital Lease Obligation increased from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹150 Mil) but then declined from Sep. 2024 (₹150 Mil) to Dec. 2024 (₹0 Mil).

Rossari Biotech's annual Long-Term Capital Lease Obligation stayed the same from Mar. 2022 (₹0 Mil) to Mar. 2023 (₹0 Mil) but then increased from Mar. 2023 (₹0 Mil) to Mar. 2024 (₹109 Mil).

Rossari Biotech Long-Term Capital Lease Obligation Historical Data

The historical data trend for Rossari Biotech's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rossari Biotech Long-Term Capital Lease Obligation Chart

Rossari Biotech Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

109.06

Rossari Biotech Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	109.06	-	149.90	-

Rossari Biotech (BOM:543213) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Rossari Biotech Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Rossari Biotech's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Rossari Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Rossari Biotech Ltd (BOM:543213) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

ROSSARI:India

Address

L.B.S. Marg, next to GE Gardens, 201 A and B, 2nd Floor, Akruti Corporate Park, Kanjurmarg (West), Mumbai, MH, IND, 400 078

Website

https://www.rossari.com

Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry and animal feed industries through its diversified product portfolio comprising home, personal care and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories home, personal care and performance chemicals; textile specialty chemicals; and; animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals and pulp and paper, and cleaning chemical formulations, among others.

Rossari Biotech Headlines

No Headlines